Patients' practices and experiences of using nebuliser therapy in the management of COPD at home
- PMID: 25806114
- PMCID: PMC4360584
- DOI: 10.1136/bmjresp-2014-000076
Patients' practices and experiences of using nebuliser therapy in the management of COPD at home
Abstract
Background and aim: How patients use their nebulisers at home is vital to ensure effective treatment and optimal health outcomes for patients with chronic obstructive pulmonary disease (COPD). The aim of the study was to identify the practicalities and problems associated with nebuliser use by patients with COPD at home, which may impact on the safety and effectiveness of therapy.
Design and setting: A cross-sectional descriptive study in which participants were recruited from two levels of care: primary care, involving 38 GP practices in North West London, and intermediate care with a major acute hospital.
Method: In-depth interviews were conducted with a representative sample of 50 patients with COPD using nebulisers in their home, recruited from general practice populations and at hospital discharge. A checklist was used to record activities and patients demonstrated use of their nebuliser. Qualitative procedures were employed to identify the range of problems experienced with nebuliser use.
Results: A wide range of practical issues was identified at all stages: problems prior to nebulisation: setting up equipment, lack of instructions, manual dexterity and time required. Problems during medication administration: inhalation technique, duration of nebulisation and understanding how to achieve optimal efficacy. Problems post-administration: inadequate cleaning of nebuliser components, access to accessories and use of damaged parts or self-repairs. Other problems included noise, weight and non-portability of equipment.
Conclusions: Patients with COPD using nebulisers at home experienced problems with all aspects, many of which may be anticipated to compromise clinical outcomes. Healthcare providers should be aware of these problems to effectively support patients with COPD with the use of their nebulisers at home.
Keywords: Nebuliser therapy.
Similar articles
-
Assistance of family carers for patients with COPD using nebulisers at home: a qualitative study.Eur J Hosp Pharm. 2016 May;23(3):156-160. doi: 10.1136/ejhpharm-2015-000735. Epub 2015 Nov 2. Eur J Hosp Pharm. 2016. PMID: 31156838 Free PMC article.
-
Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease.BMJ Open Respir Res. 2014 Feb 27;1(1):e000018. doi: 10.1136/bmjresp-2013-000018. eCollection 2014. BMJ Open Respir Res. 2014. PMID: 25478172 Free PMC article.
-
Domiciliary nebuliser therapy--a valuable option in chronic asthma and chronic obstructive pulmonary disease?Scott Med J. 1998 Apr;43(2):48-51. doi: 10.1177/003693309804300207. Scott Med J. 1998. PMID: 9717205 Clinical Trial.
-
[Nebuliser therapy].Tuberk Toraks. 2003;51(3):325-32. Tuberk Toraks. 2003. PMID: 15143414 Review. Turkish.
-
Nebuliser therapy in critical care: The past, present and future.J Intensive Care Soc. 2024 Feb;25(1):78-88. doi: 10.1177/17511437231199899. Epub 2023 Sep 20. J Intensive Care Soc. 2024. PMID: 39323591 Free PMC article. Review.
Cited by
-
Assistance of family carers for patients with COPD using nebulisers at home: a qualitative study.Eur J Hosp Pharm. 2016 May;23(3):156-160. doi: 10.1136/ejhpharm-2015-000735. Epub 2015 Nov 2. Eur J Hosp Pharm. 2016. PMID: 31156838 Free PMC article.
-
Recalibrating Perceptions and Attitudes Toward Nebulizers versus Inhalers for Maintenance Therapy in COPD: Past as Prologue.Int J Chron Obstruct Pulmon Dis. 2024 Nov 28;19:2571-2586. doi: 10.2147/COPD.S491275. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39629181 Free PMC article. Review.
-
Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs).Pharmaceuticals (Basel). 2021 Oct 19;14(10):1059. doi: 10.3390/ph14101059. Pharmaceuticals (Basel). 2021. PMID: 34681283 Free PMC article.
-
The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD.Pulm Ther. 2023 Sep;9(3):345-357. doi: 10.1007/s41030-023-00233-z. Epub 2023 Jul 20. Pulm Ther. 2023. PMID: 37470971 Free PMC article. Review.
-
In vitro bio-characterization of solid lipid nanoparticles of favipiravir in A549 human lung epithelial cancer cells.J Taibah Univ Med Sci. 2023 Mar 10;18(5):1076-1086. doi: 10.1016/j.jtumed.2023.02.014. eCollection 2023 Oct. J Taibah Univ Med Sci. 2023. PMID: 36994222 Free PMC article.
References
-
- O'Driscoll R. Home nebulized therapy: is it effective? Respir Med 1991;85:1–3 doi:10.1016/S0954-6111(06)80202-7 - DOI - PubMed
-
- Jarvis S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients: time for re-evaluation? Age Ageing 2007;36:213–18 doi:10.1093/ageing/afl174 - DOI - PubMed
-
- O'Driscoll BR, Kay EA, Taylor RJ et al. . A long-term prospective assessment of home nebulizer treatment. Respir Med 1992;86:317–25 doi:10.1016/S0954-6111(06)80031-4 - DOI - PubMed
-
- Bosley CM, Corden ZM, Rees PJ et al. . Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996;9:2346–50 doi:10.1183/09031936.96.09112346 - DOI - PubMed
-
- Corden ZM, Bosley CM, Rees PJ et al. . Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest 1997;112:1278–82 doi:10.1378/chest.112.5.1278 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources